WASHINGTON, Feb 22: For people previously infected with COVID-19, their risk of hospitalisation or death is 88 per cent lower for at least 10 months compared to those who had not been previously infected, according to a study published in The Lancet journal. The analysis also suggests that the level and duration of protection against reinfection, symptomatic disease and severe illness is at least on a par with that provided by two doses of the mRNA vaccines (Moderna, Pfizer-BioNtech) for […]
Previous COVID-19 may slash severe illness at reinfection by 89% umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
In a recent study published in the Lancet, researchers performed a systematic review of scientific literature published from inception up to September 31, 2022, that documented the reduction in risk of coronavirus disease 2019 (COVID-19) among individuals with a prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vis-à-vis those with no COVID-19 history.
While the research suggests that natural immunity could be just as good as vaccines at preventing serious illness from COVID-19 infection, the study's authors encourage people to still get vaccinated, to avoid any complications from any initial.